The Cancer Discovery Hub (CDH)

CDH is housed at the molecular diagnostic core within the National Cancer Centre Singapore. We offer a wide range of state-of-the-art, research-grade assays trusted by clinician-researchers and scientists, including single cell sequencing, spatial transcriptomics and multi-omic profiling. Our services have been successfully employed by clients and collaborators internationally including those from Singapore, Thailand, China, Taiwan and South Korea.

We are a dynamic team of clinicians and scientists, and are well-poised to provide integrated clinical and technical input to support all cancer related projects.


Our core capabilities include:

  • NGS library preparation
  • NanoString nCounter MAX system
  • Silicon Biosystems DEPArray
  • 10X Chromium and Visium
  • Tumor models
  • Functional assays
Other capabilties:
  • Laser capture microdissection
  • Qiagen GeneReader NGS system
  • Fluidigm's C1 Single-Cell Auto Prep System